During the past decade, Alzheimer's Memory Center conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 15 clinical trials were completed, i.e. on average, 51.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 10 clinical trials were completed. i.e. 90.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alzheimer's Memory Center" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Eisai Inc." with 2 trials sponsored and "Neurotrope Bioscience, Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alzheimer's Memory Center" #1 collaborator was "National Institute on Aging (NIA)" with 5 trials as a collaborator, "Alzheimer's Association" with 2 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Alzheimer's Memory Center" are "Alzheimer Disease" (15 trials), "Alzheimer's Disease" (7 trials), "Alzheimers Disease" (2 trials), "Early Alzheimer's Disease" (2 trials) and "Agitation and Aggression in Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Alzheimer's Memory Center" in a lesser frequency.

Most popular intervention types in "Alzheimer's Memory Center" are "Drug" (32 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Gantenerumab" (6 trials), "BI 409306" (2 trials), "Lecanemab" (2 trials) and "15mg T3D-959" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alzheimer's Memory Center" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Alzheimer's Memory Center". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Alzheimer's Memory Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Alzheimer's Memory Center, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".